MedPath

Calcitriol

CALCITRIOL - calcitriol oral solution Patrin Pharma, Inc.

Approved
Approval ID

c5c37779-0c26-438f-b1ca-61cf9915d233

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 2, 2023

Manufacturers
FDA

Patrin Pharma, Inc

DUNS: 806841677

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Calcitriol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code39328-042
Application NumberANDA203973
Product Classification
M
Marketing Category
C73584
G
Generic Name
Calcitriol
Product Specifications
Route of AdministrationORAL
Effective DateAugust 21, 2023
FDA Product Classification

INGREDIENTS (4)

BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2U
Classification: IACT
MEDIUM-CHAIN TRIGLYCERIDESInactive
Code: C9H2L21V7U
Classification: IACT
CalcitriolActive
Quantity: 1 ug in 1 mL
Code: FXC9231JVH
Classification: ACTIB
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171K
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Calcitriol - FDA Drug Approval Details